USITC Investigates Chinese Biotech State Support and Pricing

The U.S. International Trade Commission (USITC) has initiated a new fact-finding investigation, designated Inv. No. 332-610, to examine Chinese state support and pricing practices within the biotechnology sector. This investigation, prompted by a Senate Appropriations Committee report, will specifically assess how these practices affect the market share and competitiveness of the U.S. biotechnology industry, including areas like genomic sequencing, synthetic biology, and API manufacturing.

Regulated entities and interested parties should note the various deadlines for participation, including requests to appear at the public hearing by May 11, 2026, and the submission of posthearing briefs by June 11, 2026. The public hearing is scheduled for May 27-28, 2026. While this is a fact-finding investigation and the USITC will not make policy recommendations, the findings will be published by January 22, 2027, providing crucial insights into the competitive landscape. Compliance officers should ensure any relevant submissions are made by the specified deadlines.